What is the current valuation of the Skin Biopsy Market as of 2024?

The Skin Biopsy Market was valued at 149.87 USD Million in 2024. Read More

What is the projected market valuation for the Skin Biopsy Market in 2035?

The market is projected to reach 283.92 USD Million by 2035. Read More

What is the expected CAGR for the Skin Biopsy Market during the forecast period 2025 - 2035?

The expected CAGR for the Skin Biopsy Market during 2025 - 2035 is 5.94%. Read More

Which companies are considered key players in the Skin Biopsy Market?

Key players include DermTech, Aclaris Therapeutics, Histogenics Corporation, and others. Read More

What are the main applications of skin biopsies in the market?

The main applications include Diagnostic, Therapeutic, and Research, with valuations of 59.95, 44.92, and 45.0 USD Million respectively. Read More

How do the different types of skin biopsy compare in terms of market valuation?

Shave Biopsy leads with a valuation of 54.87 USD Million, followed by Punch Biopsy at 40.0 USD Million. Read More

What is the market valuation for skin biopsies by end use in 2024?

In 2024, Hospitals accounted for 59.95 USD Million, while Diagnostic Laboratories and Research Institutions followed with 44.92 and 45.0 USD Million respectively. Read More

What techniques are utilized in the Skin Biopsy Market?

The techniques include Surgical Biopsy, Needle Biopsy, and Endoscopic Biopsy, with Surgical Biopsy valued at 60.0 USD Million. Read More

What types of samples are analyzed in skin biopsies?

The sample types include Skin Lesions, Tumors, and Inflammatory Conditions, with Skin Lesions valued at 50.0 USD Million. Read More

How is the Skin Biopsy Market expected to evolve by 2035?

The market is likely to expand significantly, driven by advancements in technology and increasing demand for diagnostic procedures. Read More

Skin Biopsy Market

Skin Biopsy Market Research Report By Procedure Type (Excisional Biopsy, Incisional Biopsy, Shave Biopsy, Punch Biopsy), By Type of Biopsy (Surgical Biopsy, Needle Biopsy, Liquid Biopsy), By End User (Diagnostic Laboratories, Hospitals, Research Institutions), By Application (Cancer Diagnosis, Infectious Disease Diagnosis, Autoimmune Disorders) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.94%

2024 Market Size

$ 149.87 Million

2035 Market Size

$ 283.92 Million

Medical Device ● Updated August 2026 Report ID: MRFR/MED/3229-HCR | Pages: 110 | Author: Vikita Thakur, Kinjoll Dey

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Diagnostic
  2. 4.1.2 Therapeutic
  3. 4.1.3 Research
2. 4.2 Healthcare, BY Type (USD Million)
  1. 4.2.1 Excisional Biopsy
  2. 4.2.2 Incisional Biopsy
  3. 4.2.3 Punch Biopsy
  4. 4.2.4 Shave Biopsy
3. 4.3 Healthcare, BY End Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Research Institutions
4. 4.4 Healthcare, BY Technique (USD Million)
  1. 4.4.1 Surgical Biopsy
  2. 4.4.2 Needle Biopsy
  3. 4.4.3 Endoscopic Biopsy
5. 4.5 Healthcare, BY Sample Type (USD Million)
  1. 4.5.1 Skin Lesions
  2. 4.5.2 Tumors
  3. 4.5.3 Inflammatory Conditions
6. 4.6 Healthcare, BY Region (USD Million)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 DermTech (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Aclaris Therapeutics (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Histogenics Corporation (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 MediWound Ltd. (IL)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sientra, Inc. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Avita Medical (AU)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Tissue Regenix Group (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Elekta AB (SE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY TYPE
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 US MARKET ANALYSIS BY TECHNIQUE
7. 6.7 US MARKET ANALYSIS BY SAMPLE TYPE
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY TYPE
10. 6.10 CANADA MARKET ANALYSIS BY END USE
11. 6.11 CANADA MARKET ANALYSIS BY TECHNIQUE
12. 6.12 CANADA MARKET ANALYSIS BY SAMPLE TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY TYPE
16. 6.16 GERMANY MARKET ANALYSIS BY END USE
17. 6.17 GERMANY MARKET ANALYSIS BY TECHNIQUE
18. 6.18 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 UK MARKET ANALYSIS BY TYPE
21. 6.21 UK MARKET ANALYSIS BY END USE
22. 6.22 UK MARKET ANALYSIS BY TECHNIQUE
23. 6.23 UK MARKET ANALYSIS BY SAMPLE TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
25. 6.25 FRANCE MARKET ANALYSIS BY TYPE
26. 6.26 FRANCE MARKET ANALYSIS BY END USE
27. 6.27 FRANCE MARKET ANALYSIS BY TECHNIQUE
28. 6.28 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
30. 6.30 RUSSIA MARKET ANALYSIS BY TYPE
31. 6.31 RUSSIA MARKET ANALYSIS BY END USE
32. 6.32 RUSSIA MARKET ANALYSIS BY TECHNIQUE
33. 6.33 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
35. 6.35 ITALY MARKET ANALYSIS BY TYPE
36. 6.36 ITALY MARKET ANALYSIS BY END USE
37. 6.37 ITALY MARKET ANALYSIS BY TECHNIQUE
38. 6.38 ITALY MARKET ANALYSIS BY SAMPLE TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
40. 6.40 SPAIN MARKET ANALYSIS BY TYPE
41. 6.41 SPAIN MARKET ANALYSIS BY END USE
42. 6.42 SPAIN MARKET ANALYSIS BY TECHNIQUE
43. 6.43 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY TYPE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY END USE
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY TECHNIQUE
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
51. 6.51 CHINA MARKET ANALYSIS BY TYPE
52. 6.52 CHINA MARKET ANALYSIS BY END USE
53. 6.53 CHINA MARKET ANALYSIS BY TECHNIQUE
54. 6.54 CHINA MARKET ANALYSIS BY SAMPLE TYPE
55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
56. 6.56 INDIA MARKET ANALYSIS BY TYPE
57. 6.57 INDIA MARKET ANALYSIS BY END USE
58. 6.58 INDIA MARKET ANALYSIS BY TECHNIQUE
59. 6.59 INDIA MARKET ANALYSIS BY SAMPLE TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
61. 6.61 JAPAN MARKET ANALYSIS BY TYPE
62. 6.62 JAPAN MARKET ANALYSIS BY END USE
63. 6.63 JAPAN MARKET ANALYSIS BY TECHNIQUE
64. 6.64 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY TYPE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY END USE
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY TECHNIQUE
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
71. 6.71 MALAYSIA MARKET ANALYSIS BY TYPE
72. 6.72 MALAYSIA MARKET ANALYSIS BY END USE
73. 6.73 MALAYSIA MARKET ANALYSIS BY TECHNIQUE
74. 6.74 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
76. 6.76 THAILAND MARKET ANALYSIS BY TYPE
77. 6.77 THAILAND MARKET ANALYSIS BY END USE
78. 6.78 THAILAND MARKET ANALYSIS BY TECHNIQUE
79. 6.79 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
81. 6.81 INDONESIA MARKET ANALYSIS BY TYPE
82. 6.82 INDONESIA MARKET ANALYSIS BY END USE
83. 6.83 INDONESIA MARKET ANALYSIS BY TECHNIQUE
84. 6.84 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF APAC MARKET ANALYSIS BY TYPE
87. 6.87 REST OF APAC MARKET ANALYSIS BY END USE
88. 6.88 REST OF APAC MARKET ANALYSIS BY TECHNIQUE
89. 6.89 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
92. 6.92 BRAZIL MARKET ANALYSIS BY TYPE
93. 6.93 BRAZIL MARKET ANALYSIS BY END USE
94. 6.94 BRAZIL MARKET ANALYSIS BY TECHNIQUE
95. 6.95 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
97. 6.97 MEXICO MARKET ANALYSIS BY TYPE
98. 6.98 MEXICO MARKET ANALYSIS BY END USE
99. 6.99 MEXICO MARKET ANALYSIS BY TECHNIQUE
100. 6.100 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
102. 6.102 ARGENTINA MARKET ANALYSIS BY TYPE
103. 6.103 ARGENTINA MARKET ANALYSIS BY END USE
104. 6.104 ARGENTINA MARKET ANALYSIS BY TECHNIQUE
105. 6.105 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNIQUE
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY TYPE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USE
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY TECHNIQUE
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY TYPE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USE
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY TECHNIQUE
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
123. 6.123 REST OF MEA MARKET ANALYSIS BY TYPE
124. 6.124 REST OF MEA MARKET ANALYSIS BY END USE
125. 6.125 REST OF MEA MARKET ANALYSIS BY TECHNIQUE
126. 6.126 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
135. 6.135 HEALTHCARE, BY TYPE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
137. 6.137 HEALTHCARE, BY END USE, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
139. 6.139 HEALTHCARE, BY TECHNIQUE, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY TECHNIQUE, 2024 TO 2035 (USD Million)
141. 6.141 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Million)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.2.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.3.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.3.3 BY END USE, 2025-2035 (USD Million)
  4. 7.3.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.3.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.4.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.4.3 BY END USE, 2025-2035 (USD Million)
  4. 7.4.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.4.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.5.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.5.3 BY END USE, 2025-2035 (USD Million)
  4. 7.5.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.5.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.6.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.6.3 BY END USE, 2025-2035 (USD Million)
  4. 7.6.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.6.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.7.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.7.3 BY END USE, 2025-2035 (USD Million)
  4. 7.7.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.7.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.8.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.8.3 BY END USE, 2025-2035 (USD Million)
  4. 7.8.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.8.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.9.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.9.3 BY END USE, 2025-2035 (USD Million)
  4. 7.9.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.9.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.10.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.10.3 BY END USE, 2025-2035 (USD Million)
  4. 7.10.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.10.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.11.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.11.3 BY END USE, 2025-2035 (USD Million)
  4. 7.11.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.11.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.12.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.12.3 BY END USE, 2025-2035 (USD Million)
  4. 7.12.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.12.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.13.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.13.3 BY END USE, 2025-2035 (USD Million)
  4. 7.13.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.13.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.14.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.14.3 BY END USE, 2025-2035 (USD Million)
  4. 7.14.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.14.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.15.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.15.3 BY END USE, 2025-2035 (USD Million)
  4. 7.15.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.15.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.16.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.16.3 BY END USE, 2025-2035 (USD Million)
  4. 7.16.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.16.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.17.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.17.3 BY END USE, 2025-2035 (USD Million)
  4. 7.17.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.17.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.18.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.18.3 BY END USE, 2025-2035 (USD Million)
  4. 7.18.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.18.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.19.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.19.3 BY END USE, 2025-2035 (USD Million)
  4. 7.19.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.19.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.20.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.20.3 BY END USE, 2025-2035 (USD Million)
  4. 7.20.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.20.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.21.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.21.3 BY END USE, 2025-2035 (USD Million)
  4. 7.21.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.21.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.22.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.22.3 BY END USE, 2025-2035 (USD Million)
  4. 7.22.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.22.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.23.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.23.3 BY END USE, 2025-2035 (USD Million)
  4. 7.23.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.23.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.24.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.24.3 BY END USE, 2025-2035 (USD Million)
  4. 7.24.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.24.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.25.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.25.3 BY END USE, 2025-2035 (USD Million)
  4. 7.25.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.25.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.26.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.26.3 BY END USE, 2025-2035 (USD Million)
  4. 7.26.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.26.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.27.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.27.3 BY END USE, 2025-2035 (USD Million)
  4. 7.27.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.27.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.28.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.28.3 BY END USE, 2025-2035 (USD Million)
  4. 7.28.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.28.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.29.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.29.3 BY END USE, 2025-2035 (USD Million)
  4. 7.29.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.29.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.30.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.30.3 BY END USE, 2025-2035 (USD Million)
  4. 7.30.4 BY TECHNIQUE, 2025-2035 (USD Million)
  5. 7.30.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Skin Biopsy Market Segmentation

Skin Biopsy Market By Application (USD Million, 2025-2035)

Diagnostic
Therapeutic
Research

Skin Biopsy Market By Type (USD Million, 2025-2035)

Excisional Biopsy
Incisional Biopsy
Punch Biopsy
Shave Biopsy

Skin Biopsy Market By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutions

Skin Biopsy Market By Technique (USD Million, 2025-2035)

Surgical Biopsy
Needle Biopsy
Endoscopic Biopsy

Skin Biopsy Market By Sample Type (USD Million, 2025-2035)

Skin Lesions
Tumors
Inflammatory Conditions

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”